AbCellera Investor Conference Presentation Deck

CORPORATE OVERVIEW COPYRIGHT © ABCELLERA 21 ILLUSTRATIVE REVENUE PROFILE FOR ONE SUCCESSFUL PARTNERED PROGRAM AbCellera participation in programs is strongly weighted towards downstream success. Years since program start Stage of program development 1y research fees $3 million 2y 3y discovery & preclinical 4y phase 1 5y clinical milestones $9 million 6y 7y phase 2 8y 9y phase 3 10y approval & commercial milestones $85 million 11y 12y 13y commercial sales || 14y Key assumptions, hypothetical: $1.7 billion peak sales, no price inflation, no patient population growth, 5% royalty, 6 years to peak sales, 5 years at peak sales, US approval only royalties in aggregate of $765 million 15y 16y 17y 18y 19y 20y 21y

View entire presentation